M&A activity snapshot
Dermatology was one of the first physician specialties to consolidate under private equity, and it remains among the most penetrated. A 2019 study found PE penetration was highest in dermatology, with 7.5% of dermatologists working in a PE-acquired practice. A 2023 study estimated 10% to 15% of all private dermatology practices are backed by PE firms.
Deal flow peaked before COVID and has since moderated. An earlier study counted 17 PE groups acquiring 184 practices over six years, about 381 clinics overall, with about 36% of acquired practices in Texas and Florida. PitchBook data cited by VMG Health shows 134 PE dermatology transactions in 2020-2022, versus 171 in 2017-2019.
Medspas are a separate, far less consolidated market. AmSpa counted 10,488 medical spas in 2023, up from 8,899 in 2022. 81% of medical spas are single-location, and only 3% are owned by private equity firms.
Who is buying
Dermatology buyers are mostly PE-backed management groups, now numbering in the dozens. A Physician Growth Partners white paper counts over 35 PE-backed dermatology platforms throughout nearly 20 states. Forefront Dermatology had over 200 dermatology clinics across 22 states when Partners Group agreed to acquire it from OMERS Private Equity.
The current phase is platforms combining. QualDerm Partners and Pinnacle Dermatology merged in 2022, supporting 158 practices in 17 states. Schweiger Dermatology acquired United Skin Specialists' 10 office locations in January 2024, then filed to acquire CSI Medical Group, which offers services at 48 locations across 15 California counties.
Medspa buyers include dermatology platforms adding cash-pay services. Advisers interviewed by Healio expect PE-backed dermatology groups to acquire smaller practices to integrate cosmetic dermatology, plastic surgery and medspas. Multi-site medspa operators are a second pool: multi-location medical spas have nine locations on average, up from six.
What buyers look for
For dermatology, buyers underwrite the payer mix and the provider model. In other markets, about a quarter of Schweiger patient revenue is from government payors. Physician capacity is scarce, and VMG notes the scarcity of board-certified dermatologists may pose hiring and retention challenges. Supervision records also get diligence, since virtually all states require that physician assistants only provide services within the scope of care of a supervising physician.
For medspas, buyers look at repeat business and ticket size. AmSpa reports an average of 73% of medical spa patients are repeat patients, an average of 245 patient visits per month, and an average spend of $527 per visit.
Ownership and medical-direction structure is the main legal diligence item. 67% of single-owner practices are owned by non-MDs/surgeons, and 74% of medical directors come from non-core specialties. Each of those facts has to be squared with the target state's corporate-practice rules.
What makes a strong company
A dermatology practice or medspa that draws platform interest typically shows:
- For dermatology, multiple board-certified dermatologists with a documented supervision model for physician assistants and nurse practitioners.
- A medical-dermatology base with cosmetic services layered on, rather than cosmetic revenue alone.
- For medspas, repeat-patient share at or above the 73% industry average and revenue above the $1,398,833 average.
- An ownership structure that already complies with state corporate-practice and fee-splitting law, so the buyer does not have to restructure at close.
- A stable medical director. 48% of medical spas hired a medical director in the past year, so continuity in that role stands out.
- Clean records on regulated services such as elective IV therapy, now subject to added rules in some states.
Valuation and deal structure
Public multiple data specific to dermatology or medspas is thin. Most platform deals do not disclose EBITDA, and the major lower-middle-market data providers do not break out either vertical. The closest broad benchmark is GF Data, where healthcare services moderated to 7.7x in 1H 2026, though a small sample warrants caution. Treat that as a cross-sector proxy, not a dermatology or medspa multiple.
Disclosed deal terms show how platform deals are paid. In Schweiger's California filing, consideration consists of $60,000,000 in cash plus preferred and common units valued at $51,500,000. Part of the price was paid in equity of the buyer's holding company.
Ownership structures follow corporate-practice law. Under California's rules, if a medspa is a professional corporation, 51% must be owned by licensed physicians. AmSpa warns that hiring a physician medical director for a non-physician-owned medspa is illegal in Illinois. In the Schweiger filing, SDG Mgmt, a management services organization, provides non-clinical administrative services to dermatology practices in eight states.
State transaction review adds time. California's OHCA requires notice when the proposed fair market value of the transaction is $25 million or more. In the Schweiger filing, OHCA set a date by which it could waive or require a cost and market impact review.
Outlook
Expect dermatology consolidation to continue mainly as platform-to-platform deals over the next 12-24 months. Advisers expect PE investors nearing fund-end to drive the consolidation of consolidators, eventually condensing to 10 or 15 active dermatology consolidators. Independent practices will face fewer, larger bidders.
Medspa regulation is tightening state by state. Texas HB 3749 limits elective IV therapy outside medical settings: administration can be delegated only to a physician assistant, advanced practice registered nurse or registered nurse under adequate supervision. Indiana will require medical spas to register with the medical board beginning January 1, 2027, with nearly identical bills in Iowa, Florida, Arizona and Colorado.
Growth in the underlying market supports demand. AmSpa describes a medical aesthetics industry that has eclipsed $17 billion and is growing by more than $1 billion per year. Medspas with documented compliance and repeat patients should be best placed for platform buyers.
Own a dermatology practice or medspa and want a sense of what it could be worth before you talk to anyone? Run the valuation tool or see the broader healthcare services M&A picture. See also: how independent sponsors build deal flow in fragmented niches.